| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 5,873,801 | 5,349,119 |
| Net increase in cash and cash equivalents | 855,764 | 2,164,455 |
| Cash and cash equivalents at beginning of period | 3,750,525 | - |
| Cash and cash equivalents at end of period | 4,606,289 | - |
ADIAL PHARMACEUTICALS, INC. (ADIL)
ADIAL PHARMACEUTICALS, INC. (ADIL)